Positions

Overview

  • Dr. Franco is board certified in Internal Medicine and Infectious Diseases and Assistant Professor of Medicine at the University of Alabama at Birmingham. His interest focuses on interventions to improve access to care and new therapies in Chronic Hepatitis C; clinical management and trials in HCV mono-infection and HIV-HCV co-infection; and the accelerated pathogenesis of HIV-HCV co-infection. Recently, Dr. Franco had coordinated the Hep C Circle of Care award, instrumental in the expansion of the 1917 Viral Hepatitis Clinic. Since then, the 1917 Viral Hepatitits Clinic had developed collaborations with the Liver Center, the Department of Emergency Medicine and Charity Care at UAB, becoming a major point of linkage to Hepatitis C care for a broad referral base in the State of Alabama.
  • Research Overview

  • Public Health and Outcomes Research in hepatitis C and HIV.
  • Investigator On

  • VVTEU Protocol Development and Implementation for Task Areas B-C Phase II Vaccine Trial for Influenza (“Flu Pandemic” or “H7”)  awarded by VANDERBILT UNIVERSITY MEDICAL CENTER 2014 - 2023
  • Vaccine and Treatment Evaluation Units  awarded by VANDERBILT UNIVERSITY MEDICAL CENTER 2014 - 2023
  • Vaccine and Treatment Evaluation Units - Admin Task  awarded by VANDERBILT UNIVERSITY 2014 - 2023
  • Private Grant  awarded by Gilead Sciences 2018 - 2022
  • Private Grant  awarded by PROTEUS DIGITAL HEALTH, INC. 2017 - 2022
  • Private Grant  awarded by GlaxoSmithKline 2014 - 2022
  • Initiating Medication Assisted Treatment of Opioid Addiction in the Emergency Department: The ED MAT Protocol  awarded by Substance Abuse & Mental Health Services Administration 2019 - 2022
  • Private Grant  awarded by GlaxoSmithKline 2018 - 2022
  • Private Grant  awarded by BAVARIAN NORDIC A/S 2019 - 2021
  • Private Grant  awarded by VIIV HEALTHCARE COMPANY 2016 - 2021
  • Private Grant  awarded by VIIV HEALTHCARE COMPANY 2016 - 2021
  • Private Grant  awarded by VIIV HEALTHCARE COMPANY 2016 - 2021
  • Alabama Clinical Trials Unit (CTU)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2017 - 2020
  • HVTN 703/HPTN 081 Protocol Funding (PF)  awarded by Hutchinson (Fred) Cancer Research Center 2015 - 2020
  • Private Grant  awarded by GlaxoSmithKline 2019 - 2020
  • Private Grant  awarded by Gilead Sciences 2019 - 2020
  • Private Grant  awarded by GENECURE BIOTECHNOLOGIES, LLC 2015 - 2020
  • Private Grant  awarded by Gilead Sciences 2016 - 2020
  • ACTG Protocol Funds  awarded by University of California, Los Angeles 2018 - 2019
  • Private Grant  awarded by Gilead Sciences 2016 - 2019
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2017 - 2019
  • HVTN Protocol Funding (PF)  awarded by Hutchinson (Fred) Cancer Research Center 2015 - 2018
  • NIAID-Fred Hutch-Janssen Collaboration CTU/Clinical Trial Site Activities for HVTN 117/118  awarded by Hutchinson (Fred) Cancer Research Center 2015 - 2018
  • AIDS Clinical Trials Group: Protocol Funds FTE Funding  awarded by Brigham and Women's Hospital 2014 - 2018
  • Private Grant  awarded by Gilead Sciences 2014 - 2018
  • Private Grant  awarded by Gilead Sciences 2015 - 2018
  • Alabama Clinical Trials Unit (CTU)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2017
  • Private Grant  awarded by ABBVIE INC 2013 - 2017
  • Private Grant  awarded by Gilead Sciences 2012 - 2017
  • Private Grant  awarded by Gilead Sciences 2012 - 2017
  • Private Grant  awarded by MERCK & COMPANY, INC. 2014 - 2017
  • Private Grant  awarded by Gilead Sciences 2015 - 2017
  • Private Grant  awarded by GENOCEA BIOSCIENCES, INC. 2015 - 2017
  • Private Grant  awarded by BAVARIAN NORDIC A/S 2014 - 2017
  • Private Grant  awarded by GENOCEA BIOSCIENCES, INC. 2015 - 2016
  • Private Grant  awarded by Gilead Sciences 2015 - 2016
  • Private Grant  awarded by CEPHEID 2015 - 2016
  • Alabama Coalition for Testing, Interventions, and Engagement in Hepatitis C Care (ACTIVE-Care)  awarded by GILEAD FOUNDATION 2015 - 2016
  • Private Grant  awarded by GENOCEA BIOSCIENCES, INC. 2014 - 2016
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2012 - 2016
  • Private Grant  awarded by Gilead Sciences 2012 - 2016
  • Private Grant  awarded by VICAL, INC. 2014 - 2016
  • Private Grant  awarded by Gilead Sciences 2013 - 2016
  • Private Grant  awarded by VERTEX PHARMACEUTICALS, INC. 2012 - 2016
  • HCV Early Identification and Linkage to Care  awarded by CDC Foundation 2013 - 2015
  • Private Grant  awarded by GlaxoSmithKline 2015
  • HVTN Protocol Funding (PF)  awarded by Hutchinson (Fred) Cancer Research Center 2014 - 2015
  • Private Grant  awarded by MERCK & COMPANY, INC. 2014 - 2015
  • Private Grant  awarded by Gilead Sciences 2013 - 2015
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2014 - 2015
  • Private Grant  awarded by Gilead Sciences 2014 - 2015
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2013 - 2015
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2014 - 2015
  • Private Grant  awarded by ABBVIE INC 2013 - 2014
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2012 - 2014
  • Private Grant  awarded by Gilead Sciences 2012 - 2014
  • Private Grant  awarded by Gilead Sciences 2012 - 2014
  • Private Grant  awarded by Gilead Sciences 2012 - 2014
  • Private Grant  awarded by Genentech 2012 - 2014
  • Private Grant  awarded by Gilead Sciences 2012 - 2013
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2013
  • Private Grant  awarded by Gilead Sciences 2013
  • Private Grant  awarded by ABBVIE INC 2013
  • Private Grant  awarded by Gilead Sciences 2012 - 2013
  • Private Grant  awarded by Gilead Sciences 2012 - 2013
  • Private Grant  awarded by VERTEX PHARMACEUTICALS, INC. 2011 - 2013
  • Education And Training

  • Jackson Memorial Hospital, Internship 2008
  • Jackson Memorial Hospital, Residency 2010
  • UAB Hospital, Postdoctoral Fellowship 2013
  • Full Name

  • Ricardo Franco